Nara Organics Powdered Infant Formula is being voluntarily recalled after three infants were hospitalized with infant botulism.
Nara Organics is voluntarily recalling its whole milk powdered infant formula after three infants who had consumed the product were hospitalized with infant botulism, according to a notice from the Food and Drug Administration.
The Centers for Disease Control and Prevention confirmed that all three babies had consumed Nara Organics Powdered Infant Formula, which was sold at Target stores across the United States, as well as through Target.com and Nara.com. The infants were in California, Washington and Pennsylvania, the FDA notice said. All three were successfully treated, and no deaths have been reported.
The FDA said no lots of Nara Organics Powdered Infant Formula have tested positive for Clostridium botulinum , the bacteria that causes infant botulism. Still, the company is recalling all whole milk infant powdered formula products while officials investigate.
The three lots consumed by the sickened infants were 709125280E14F2, 709125288E14F2 and 708125174E14F2, according to the FDA. Lot numbers are printed on the bottom of the cans.
“Nara is taking aggressive action to ensure the safety of the babies and families who use the product as we work closely with the FDA, Centers for Disease Control and Prevention (CDC), and state partners to support their investigation into the root causes of these cases,” the company said in the FDA notice.
Customers should stop using the affected products immediately. People who bought formula from Nara.com between May and June 2026 will receive an automatic refund, while other Nara.com customers may request one online. Consumers who bought the formula at Target should return it to the store or visit Target’s website for refund information.
Infant botulism can occur when Clostridium botulinum spores enter and colonize an infant’s intestinal tract, producing toxins there, according to the CDC. Symptoms can include constipation, poor feeding, drooping eyelids, sluggish pupils, low muscle tone, trouble sucking or swallowing, weak or altered crying, breathing difficulty and generalized weakness. Respiratory arrest is possible, and the illness can be fatal.
Caregivers whose babies consumed the formula and develop symptoms should contact a healthcare provider immediately, according to the notice. The formula was not sold outside the United States.
Comments (0)